Click here to view the United Healthcare (UHC) Medical Policy Updates » December 2024 United…
Premera Blue Cross Medical Policy Updates – July 2018
Click here to view the Premera Blue Cross Medical Policy Updates »
July 2018 Medical Policy Updates:
- ALK Tyrosine Kinase Inhibitors
- Artificial Intervertebral Disc: Cervical Spine
- Artificial Intervertebral Disc: Lumbar Spine
- Axial Lumbosacral Interbody Fusion
- Bone Mineral Density Studies
- Cialis® (tadalafil) for Benign Prostatic Hyperplasia
- Cosmetic and Reconstructive Services
- Cutaneous T-Cell Lymphomas (CTCL): Systemic Therapies
- Deep Brain Stimulation
- Egrifta® (tesamorelin)
- Electrical Bone Growth Stimulation of the Appendicular Skeleton
- Electrical Stimulation of the Spine as an Adjunct to Spinal Fusion Procedures
- Energy (Laser Discectomy) or Radiofrequency Coblation Energy (Laser Discectomy) or Radiofrequency Coblation (Nucleoplasty)
- Epidermal Growth Factor Receptor (EGFR) Inhibitors
- Facet Arthroplasty
- Facet Joint Denervation
- Gender Reassignment Surgery
- General Medical Necessity Criteria for Companion Diagnostics Related to Drug Approval
- Genetic Testing for Alzheimer Disease
- Genetic Testing for Hereditary Breast / Ovarian Cancer Syndrome (BRCA1/BRCA2)
- Genetic Testing for Hereditary Hearing Loss
- Genetic Testing of CADASIL Syndrome
- Hematopoietic Stem-Cell Transplantation for Waldenstrom Macroglobulinemia
- Image-Guided Minimally Invasive Decompression for Spinal Stenosis
- Immune Globulin Therapy
- Interspinous Fixation (Fusion) Devices
- Intra-Articular Hyaluronan Injections for Osteoarthritis
- Lumbar Spine Decompression Surgery: Discectomy, Foraminotomy, Laminotomy, Laminectomy
- Medical Necessity Criteria for Pharmacy Ed
- Meniscal Allografts and Other Meniscal Implants
- Microprocessor-Controlled and Powered Prostheses for the Lower Limb
- Miscellaneous Oncology Drugs
- Monoclonal Antibodies for the Treatment of Lymphoma
- Multiple Receptor Tyrosine Kinase Inhibitors
- Occipital Nerve Stimulation
- Off-Label Use of Drugs and Biologic Agents
- Orthognathic Surgery
- Orthopedic Applications of Platelet-Rich Plasma
- Orthoptic Training for the Treatment of Vision or Learning Disabilities
- Percutaneous Balloon Kyphoplasty, Radiofrequency Kyphoplasty, and Mechanical Vertebral Augmentation
- Percutaneous Vertebroplasty and Sacroplasty
- Peripheral Subcutaneous Field Stimulation
- Pharmacologic Treatment of Neuropathy, Fibromyalgia, and Seizure Disorders
- Prostate Cancer Targeted Therapies
- Responsive Neurostimulation for the Treatment of Refractory Focal Epilepsy
- Sacral Nerve Neuromodulation/Stimulation
- Solid Organ Transplants
- Spinal Cord and Dorsal Root Ganglion Stimulation
- Subtalar Arthroereisis
- Transcatheter Aortic Valve Implantation for Aortic Stenosis
- Treatment of Hyperhidrosis
- Vertebral Axial Decompression
Click here to view the Premera Blue Cross Medical Policy Updates »
Policy Alerts monitors Commercial and Medicare medical policies for changes. While medical Insurance carriers typically update medical policies annually, there are many reasons why they might review or update a policy. When reviews occur out of cycle they often go unnoticed. Policy Alerts keeps you updated when Payers make coverage changes to medical policies affecting your business.
Policy Alerts continuously monitors Commercial and Medicare Payer coverage information to keep you up-to-date on medical Insurance decisions in real-time. When changes occur, instant email alerts are delivered to your inbox. Clients have access to detailed coverage reports and medical policies through the interactive Policy Alerts Dashboard portal. Save time each month and keep focused on important Payer medical policy reviews and coverage decisions affecting your business!
Policy Alerts takes a client-focused hands-on approach and is constantly working to provide our customers with helpful insights and actionable analytics. We understand what our clients need and are dedicated to providing timely, accurate, and always up-to-date reports.
Health economic and reimbursement information provided by Policy Alerts is gathered from third-party sources and is subject to change without notice as a result of complex and frequently changing laws, regulations, rules and policies. All product and company names are trademarks™ or registered® trademarks of their respective holders. Use of them does not imply any affiliation with or endorsement by them. This information is presented for illustrative purposes only and does not constitute reimbursement or legal advice.